Current concepts and challenges in the prevention and treatment of viral infections in immunocompromised cancer patients

Supportive Care in Cancer

Volumn 6, Issue 1, 1997, Pages 39-45

  Reusser, Pierre ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Adoptive immunotherapy; Antiviral prophylaxis; Antiviral therapy; Bone marrow transplantation; Herpesvirus infection

Indexed keywords

ACICLOVIR; ADEFOVIR DIPIVOXIL; ANTIVIRUS AGENT; BENZIMIDAVIR; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; HYPERIMMUNE GLOBULIN; LOBUCAVIR; PRODRUG; UNCLASSIFIED DRUG; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

ACUTE LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CHICKENPOX; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DRUG RESISTANCE; HERPES SIMPLEX VIRUS; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 0031953152     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050130     Document Type: Review

References (83)

1. Aschan J, Ringdén O, Ljungman P, et al (1992) Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scand J Infect Dis 24:143-150
2. Aspin VLM, Gallez-Hawkins GM, Giugni TD, et al (1994) Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microb 32:2266-2269
3. Balfour HH Jr, Bean B, Laskin OL, et al (1983) Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 308:1448-1453
4. Beutner KR, Friedmann DJ, Forszpaniak C, Andersen PL, Wood MJ (1995) Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39:1546-1553
5. Boeckh M, Bowden RA, Goodrich JM, et al (1992) Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358-1364
6. Bowden RA, Savers M, Flournoy N, et al (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314:1006-1010
7. Bowden RA, Slichter SJ, Sayers M, et al (1995) A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CVM infection after marrow transplantation. Blood 86:3598-3603
8. Bustamante CI, Wade JC (1991) Herpes simplex virus infection in the immunocompromised cancer patient. J Clin Oncol 9:1903-1915
9. Carrigan DR, Knox KK (1994) Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 84:3307-3310
10. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC (1991) Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 338:147-149
11. Chou S, Erice A, Jordan MC, et al (1995) Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 171:576-583
12. Christiansen NP, Haake RJ, Hurd DD (1991) Early herpes zoster infection in adult patients with Hodgkin's disease undergoing autologous bone marrow transplant. Bone Marrow Transplant 7:435-437
13. Cone RW, Hackman RC, Huang M-LW, et al (1993) Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329:156-161
14. Drew WL, Miner RC, Busch DF, et al (1991) Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 163:716-719
15. Drobyski WR, Dunne WM, Burd EM, et al (1993) Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 167:35-39
16. Drobyski WR, Knox KK, Majewski D, Carrigan DR (1994) Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 330:1356-1360
17. Einsele H, Steidle M, Vallbracht A, et al (1991) Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 77:1104-1110
18. Einsele H, Ehninger G, Hebart H, et al (1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86:2815-2820
19. Emanuel D, Cunningham I, Jules-Elysee K, et al (1988) Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 109:777-782
20. Englund JA, Zimmermann ME, Swierkosz EM, Goodmann JL, Scholl DR, Balfour HH Jr (1990) Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med 112:416-422
21. Enright H, Haake R, Weisdorf D, et al (1993) Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation 55:1339-1346
22. Faulds D, Heel RC (1990) Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 39:597-638
23. Feldman S, Lott L (1987) Varicella in children with cancer. Impact of antiviral therapy and prophylaxis. Pediatrics 80:465-472
24. Flomenberg P, Babbitt J, Drobyski WR, et al (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169:775-781
25. Gerna G, Furione M, Baldanti F, et al (1995) Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients. Br J Haematol 91:674-683
26. Gershon AA, Steinberg SP, and Varicella Vaccine Collaborative Study Group of the National Institute of Allergy and Infectious Diseases (1989) Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 320:892-897
27. Goodrich JM, Mori M, Gleaves CA, et al (1991) Prevention of cytomegalovirus disease after allogeneic marrow transplantation by early treatment with ganciclovir. N Engl J Med 325:1601-1607
28. Goodrich JM, Bowden RA, Fisher L, et al (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173-178
29. Han CS, Miller W, Haake R, Weisdorf D (1994) Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 13:277-283
30. Hardy I, Gershon AA, Steinberg SP, et al (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 325:1545-1550
31. Harrington RD, Hooton TM, Hackman RC, et al (1992) An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 165:987-993
32. Hill EL, Hunter GA, Ellis MN (1991) In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 35:2322-2328
33. Jacobson MA, Berger TG, Fikrig S, et al (1990) Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:187-191
34. Knox KK, Drobyski WR, Carrigan DR (1991) Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient (letter). Lancet I:1292-1293
35. Li C-R, Greenberg PD, Gilbert MJ, et al (1994) Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979
36. Ljungman P, Wilczek H, Gahrton G, et al (1986) Long term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant 1:185-192
37. Ljungman P, Gleaves CA, Meyers JD (1989) Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 4:35-40
38. Ljungman P, Andersson J, Aschan J, et al (1993) Influenza A in immunocompromised patients. Clin Infect Dis 17:244-247
39. Locksley RM, Flournoy N, Sullivan KM, Meyers JD (1985) Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 152:1172-1181
40. Mazur MH, Dolin R (1978) Herpes zoster at the NIH: a 20 year experience. Am J Med 65:738-744
41. Meyers JD (1989) Prevention of cytomegalovirus infection after marrow transplantation. Rev Infect Dis 11 [Suppl 7]:S1691-S1705
42. Meyers JD, Flournoy N, Thomas ED (1980) Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis 142:338-346
43. Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478-488
44. Meyers JD, Reed EC, Shepp DH, et al (1988) Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 318:70-75
45. Meyers JD, Ljungman P, Fisher LD (1990) Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 162:373-380
46. Perren TJ, Powles RL, Easten D, et al (1988) Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. Am J Med 85 [Suppl 2A]:99-101
47. Prentice HG, Gluckman E, Powles RL, et al (1994) Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet 343:749-753
48. Prober CG, Kirk LE, Keeney RE (1982) Acyclovir therapy of chicken-pox in immunosuppressed children - a collaborative study. J Pediatr 101:622-625
49. Pue M, Benet LZ (1993) Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother 4 [Suppl 1]:47-55
50. Reed EC, Bowden RA, Dandliker PS, et al (1988) Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 109:783-788
51. Reusser P (1994) Prophylaxis and treatment of herpes virus infections in immunocompromised cancer patients. Baillière's Clin Infect Dis 1:523-544
52. Reusser P (1996) Human cytomegalovirus infection and disease after bone marrow and solid organ transplantation. Baillière's Clin Infect Dis 3:357-371
53. Reusser P (1996) Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 33:235-248
54. Reusser P, Fisher LD, Buckner CD, Thomas ED, Meyers JD (1990) Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. Blood 75:1888-1894
55. Reusser P, Riddell SR, Meyers JD, et al (1991) Cytotoxic T lymphocyte response to cytomegalovirus following human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380
56. Reusser P, Cordonnier C, Einsele H, et al, for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (1996) European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrow Transplant 17:813-817
57. Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H (1997) Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 89:3873-3879
58. Riddell SR, Watanabe KS, Goodrich JM, et al (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238-241
59. Sable CA, Hayden FG (1995) Orthomyxoviral and paramyxoviral infections in transplant patients. Infect Dis Clin North Am 9:987-1003
60. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD, for the Canadian Famciclovir Study Group (1996) Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. JAMA 276:44-49
61. Safrin S, Elbeik T, Mills J (1994) A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J Infect Dis 169:879-882
62. Schmidt GM, Kovacs A, Zaia JA, et al (1988) Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 46:905-907
63. Schmidt GM, Horak DA, Niland JC, et al (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324:1005-1011
64. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD (1985) Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 312:529-533
65. Slavin MA, Bindra RR, Gleaves CA, Pettinger MB, Bowden RA (1993) Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients. Antimicrob Agents Chemother 37:1360-1363
66. Spencer GD, Hackman RC, McDonald GB, et al (1986) A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation 42:602-607
67. Straus SE, Ostrove JM, Inchauspé G, et al (1988) Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 108:221-237
68. Straus SE, Cohen JI, Tosato G, Meier J (1993) Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 118:45-58
69. Tyring S, Barbarash RA, Nahlik JE, et al (1995) Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:89-96
70. Vere Hodge RA, Sutton D, Boyd MR, et al (1989) Selection of an oral prodrug (BRL 42810: famciclovir) for the antiherpes virus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethyl-1-yl) guanine; penciclovir]. Antimicrob Agents Chemother 33:1765-1773
71. Wade JC (1993) Management of infection in patients with acute leukemia. Hematol Oncol Clin North Am 7:293-315
72. Wade JC, Newton B, McLaren C, et al (1982) Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation. A double-blind trial. Ann Intern Med 96:265-269
73. Wade JC, McLaren C, Meyers JD (1983) Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J Infect Dis 148:1077-1082
74. Walter EA, Greenberg PD, Gilbert MJ, et al (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038-1044
75. Weller S, Blum MR, Doucette M, et al (1993) Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 54:595-605
76. Wendt CH, Weisdorf DJ, Jordan MC, Balfour HH Jr, Hertz MI (1992) Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 326:921-926
77. Whimbey E, Elting LS, Couch RB, et al (1994) Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 13:437-440
78. Whitley RJ, Gnann JW Jr (1992) Acyclovir a decade later. N Engl J Med 327:782-789
79. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W (1994) Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 83: 3052-3058
80. Wingard JR, Piantadosi S, Burns WH, et al (1990) Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Rev Infect Dis 12 [Suppl 7]: S793-S804
81. Winston DJ, Ho WG, Bartoni K, et al (1993) Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 118:179-184
82. Zaia JA, Forman SJ (1995) Cytomegalovirus infection in the bone marrow transplant recipient. Infect Dis Clin North Am 9:879-900
83. Zutter MM, Martin PJ, Sale GE, et al (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520-529